Suzanne Aldington

Dr Suzanne Aldington is a Senior Principal Scientist at Lonza Biologics. 

She has spent 22 years at Lonza, working on purification process development, scale up and technology transfer to GMP manufacturing facilities within the Lonza network.  She has also led process validation activities at the Slough site, working with multiple biopharmaceutical companies.  She has supported many regulatory submissions and also on-site inspections by the FDA and other Health Agencies.  

Her current role at Lonza is within the Global Process Development team, working on harmonisation of activities across the global network in particular relating to purification, as well as troubleshooting and mentoring.

Suzanne also spent some time at Orchard Therapeutics, a Cell and Gene Therapy company which focuses on treatments for rare genetic diseases. Whilst there, she led the cell process and viral vector MSAT teams, supporting several clinical stage projects at different CDMO sites, with oversight of process development, manufacturing activities and process performance qualification batches as well as MAA and BLA submissions.  

A microbiologist by training, she has over 30 years’ experience in academia and in the biotechnology industry. She received a microbiology degree from Imperial College and a Ph.D in biochemical engineering from the University of Birmingham.